The growth in the historic period can be attributed to clinical need for precise adrenal diagnostics, established role in hpa testing, growth of endocrinology subspecialties, hospital diagnostic adoption, regulatory approvals for diagnostic use.
The growth in the forecast period can be attributed to increasing endocrine disorder prevalence, improved diagnostic accuracy demand, expansion of specialty diagnostic centers, rising clinical research activity, adoption in advanced hospital laboratories. Major trends in the forecast period include increasing use in endocrine diagnostic testing, growing focus on accurate hpa axis evaluation, expansion of specialized hormonal diagnostics, improved clinical differentiation of cushing’s syndrome, rising use in advanced endocrinology centers.
The increasing demand for diagnostic testing is anticipated to drive the growth of the acthrel market in the coming years. Diagnostic testing involves medical procedures used to detect or confirm the presence of diseases or health conditions in patients. The growth in diagnostic testing is driven by factors such as advancements in medical technologies, greater emphasis on early disease identification, rising health awareness, and an expanding aging population. Acthrel supports diagnostic testing by stimulating the pituitary gland to secrete adrenocorticotropic hormone (ACTH), allowing healthcare professionals to assess adrenal gland function and diagnose conditions such as adrenal insufficiency or disorders associated with the hypothalamic-pituitary-adrenal axis. For instance, in December 2024, according to the National Health Service, a UK-based government department, the number of diagnostic tests conducted reached 2,544,809 in 2024, up from 2,312,030 in 2023. Therefore, the growing demand for diagnostic testing is contributing to the expansion of the acthrel market.
The increasing prevalence of endocrine diseases is expected to fuel the growth of the acthrel market in the future. Endocrine diseases are conditions that affect the endocrine glands, resulting in disruptions in hormone production and regulation, which impact overall bodily functions. The rising incidence of endocrine disorders is largely driven by unhealthy lifestyle behaviors, as poor dietary habits, physical inactivity, and chronic stress interfere with hormonal balance and elevate the risk of metabolic and gland-related disorders. Acthrel assists in the diagnostic assessment of the hypothalamic-pituitary-adrenal (HPA) axis, enabling precise detection and management of adrenal and related endocrine conditions in response to the increasing prevalence of endocrine diseases. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Therefore, the growing incidence of endocrine diseases is driving the acthrel market.
Rising healthcare expenditure is expected to support the growth of the acthrel market going forward. Healthcare expenditure refers to the total financial resources allocated or spent on healthcare services and products over a defined period. The increase in healthcare spending is attributed to the growing prevalence of chronic diseases that require prolonged and often expensive treatment. Acthrel contributes to higher healthcare expenditure by enabling precise hypothalamic-pituitary-adrenal (HPA) axis testing, which is critical for diagnosing complex endocrine disorders such as adrenal insufficiency and Cushing’s syndrome, thereby encouraging greater investment in diagnostic technologies, treatment options, and specialized healthcare services. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% higher growth rate compared to 2022. Therefore, rising healthcare expenditure is driving the acthrel market.
Major companies operating in the acthrel market are Ferring Pharmaceuticals.
North America was the largest region in the acthrel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acthrel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acthrel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have moderately influenced the acthrel market by increasing costs for imported peptide synthesis inputs and diagnostic formulation materials. These impacts are most evident in hospital and specialty diagnostic center procurement. Higher tariffs have added cost pressure to endocrine diagnostic procedures. At the same time, tariffs are encouraging local pharmaceutical manufacturing partnerships. This improves long term availability of critical diagnostic agents.
The acthrel market research report is one of a series of new reports that provides acthrel market statistics, including acthrel industry global market size, regional shares, competitors with a acthrel market share, detailed acthrel market segments, market trends and opportunities, and any further data you may need to thrive in the acthrel industry. This acthrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Acthrel (corticorelin ovine triflutate) is a synthetic form of corticotropin-releasing hormone (CRH) used for diagnostic evaluation of hypothalamic-pituitary-adrenal (HPA) axis function. It supports the diagnosis of adrenal insufficiency, helps distinguish between different causes of Cushing’s syndrome, and is used to assess pituitary gland function in clinical settings.
The primary applications of acthrel include the diagnosis of adrenal insufficiency, hypothalamic-pituitary-adrenal (HPA) axis testing, and medical research. Diagnosis of adrenal insufficiency involves clinical assessments and laboratory tests to determine whether the adrenal glands produce sufficient hormone levels, particularly cortisol, to meet physiological requirements. Acthrel is mainly used in adult and geriatric populations and is distributed through hospitals and clinics, as well as retail and specialty pharmacies, to ensure broad availability across healthcare environments.
The acthrel market consists of sales of products such as lyophilized powder intended for injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to increasing endocrine disorder prevalence, improved diagnostic accuracy demand, expansion of specialty diagnostic centers, rising clinical research activity, adoption in advanced hospital laboratories. Major trends in the forecast period include increasing use in endocrine diagnostic testing, growing focus on accurate hpa axis evaluation, expansion of specialized hormonal diagnostics, improved clinical differentiation of cushing’s syndrome, rising use in advanced endocrinology centers.
The increasing demand for diagnostic testing is anticipated to drive the growth of the acthrel market in the coming years. Diagnostic testing involves medical procedures used to detect or confirm the presence of diseases or health conditions in patients. The growth in diagnostic testing is driven by factors such as advancements in medical technologies, greater emphasis on early disease identification, rising health awareness, and an expanding aging population. Acthrel supports diagnostic testing by stimulating the pituitary gland to secrete adrenocorticotropic hormone (ACTH), allowing healthcare professionals to assess adrenal gland function and diagnose conditions such as adrenal insufficiency or disorders associated with the hypothalamic-pituitary-adrenal axis. For instance, in December 2024, according to the National Health Service, a UK-based government department, the number of diagnostic tests conducted reached 2,544,809 in 2024, up from 2,312,030 in 2023. Therefore, the growing demand for diagnostic testing is contributing to the expansion of the acthrel market.
The increasing prevalence of endocrine diseases is expected to fuel the growth of the acthrel market in the future. Endocrine diseases are conditions that affect the endocrine glands, resulting in disruptions in hormone production and regulation, which impact overall bodily functions. The rising incidence of endocrine disorders is largely driven by unhealthy lifestyle behaviors, as poor dietary habits, physical inactivity, and chronic stress interfere with hormonal balance and elevate the risk of metabolic and gland-related disorders. Acthrel assists in the diagnostic assessment of the hypothalamic-pituitary-adrenal (HPA) axis, enabling precise detection and management of adrenal and related endocrine conditions in response to the increasing prevalence of endocrine diseases. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Therefore, the growing incidence of endocrine diseases is driving the acthrel market.
Rising healthcare expenditure is expected to support the growth of the acthrel market going forward. Healthcare expenditure refers to the total financial resources allocated or spent on healthcare services and products over a defined period. The increase in healthcare spending is attributed to the growing prevalence of chronic diseases that require prolonged and often expensive treatment. Acthrel contributes to higher healthcare expenditure by enabling precise hypothalamic-pituitary-adrenal (HPA) axis testing, which is critical for diagnosing complex endocrine disorders such as adrenal insufficiency and Cushing’s syndrome, thereby encouraging greater investment in diagnostic technologies, treatment options, and specialized healthcare services. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% higher growth rate compared to 2022. Therefore, rising healthcare expenditure is driving the acthrel market.
Major companies operating in the acthrel market are Ferring Pharmaceuticals.
North America was the largest region in the acthrel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acthrel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acthrel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have moderately influenced the acthrel market by increasing costs for imported peptide synthesis inputs and diagnostic formulation materials. These impacts are most evident in hospital and specialty diagnostic center procurement. Higher tariffs have added cost pressure to endocrine diagnostic procedures. At the same time, tariffs are encouraging local pharmaceutical manufacturing partnerships. This improves long term availability of critical diagnostic agents.
The acthrel market research report is one of a series of new reports that provides acthrel market statistics, including acthrel industry global market size, regional shares, competitors with a acthrel market share, detailed acthrel market segments, market trends and opportunities, and any further data you may need to thrive in the acthrel industry. This acthrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Acthrel (corticorelin ovine triflutate) is a synthetic form of corticotropin-releasing hormone (CRH) used for diagnostic evaluation of hypothalamic-pituitary-adrenal (HPA) axis function. It supports the diagnosis of adrenal insufficiency, helps distinguish between different causes of Cushing’s syndrome, and is used to assess pituitary gland function in clinical settings.
The primary applications of acthrel include the diagnosis of adrenal insufficiency, hypothalamic-pituitary-adrenal (HPA) axis testing, and medical research. Diagnosis of adrenal insufficiency involves clinical assessments and laboratory tests to determine whether the adrenal glands produce sufficient hormone levels, particularly cortisol, to meet physiological requirements. Acthrel is mainly used in adult and geriatric populations and is distributed through hospitals and clinics, as well as retail and specialty pharmacies, to ensure broad availability across healthcare environments.
The acthrel market consists of sales of products such as lyophilized powder intended for injection. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Acthrel Market Characteristics
3. Acthrel Market Supply Chain Analysis
4. Global Acthrel Market Trends and Strategies
5. Acthrel Market Analysis of End Use Industries
7. Global Acthrel Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Acthrel Total Addressable Market (TAM) Analysis for the Market
9. Acthrel Market Segmentation
10. Acthrel Market Regional and Country Analysis
11. Asia-Pacific Acthrel Market
12. China Acthrel Market
13. India Acthrel Market
14. Japan Acthrel Market
15. Australia Acthrel Market
16. South Korea Acthrel Market
17. Western Europe Acthrel Market
18. UK Acthrel Market
19. Germany Acthrel Market
20. France Acthrel Market
21. Eastern Europe Acthrel Market
22. North America Acthrel Market
23. USA Acthrel Market
24. Canada Acthrel Market
25. South America Acthrel Market
26. Middle East Acthrel Market
27. Africa Acthrel Market
29. Acthrel Market Competitive Landscape and Company Profiles
32. Acthrel Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Acthrel Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses acthrel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for acthrel? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acthrel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Application: Diagnosis Of Adrenal Insufficiency; Hypothalamic-Pituitary-Adrenal (HPA) Axis Testing; Medical Research2) By End User: Adult; Geriatric
3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies
Companies Mentioned: Ferring Pharmaceuticals
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Acthrel market report include:- Ferring Pharmaceuticals
